Contact Lens Dry Eye

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-10-25
Clinical Trial Update: Use of 5.0% Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease in Contact Lens Wearers [Phase 4]
A Phase 4 trial investigating 5.0% lifitegrast ophthalmic solution for dry eye disease in contact lens wearers has been withdrawn.